Why embryo selection is one of the hardest decisions in modern medicine
In-vitro fertilization is one of the most emotionally and financially demanding procedures in modern medicine. A single IVF cycle can cost tens of thousands of rupees or dollars and is built around one core decision — which embryo to transfer. That decision is currently made by embryologists who score embryos based on visual morphology, blastocyst grade, and personal experience.
The problem is that this scoring is inherently subjective: two qualified embryologists can grade the same embryo differently, leading to inconsistent IVF outcomes, lower success rates, and longer cycles for hopeful parents. Global embryo datasets exist but rarely reflect the demographic and clinical realities of Indian IVF practice, and any AI prediction that affects an embryo transfer decision must be explainable, auditable, and validated against clinical outcomes.
AI-powered embryo grading offers a way out — by training deep-learning models on tens of thousands of labeled oocyte and embryo images and grounding predictions in clinical outcome data, IVF clinics can move from subjective grading to objective, reproducible scoring. That's the gap Garbha.ai was built to close.
Subjective embryo grading
Manual visual scoring varies between embryologists, clinics, and even individual sessions — producing inconsistent IVF outcomes and obscured benchmarks.
Limited transferable datasets
Global embryo datasets exist but rarely reflect the demographic and clinical realities of Indian IVF practice — local clinical performance has to be earned, not borrowed.
High clinical trust bar
An AI prediction that affects an embryo transfer decision must be explainable, auditable, and validated against real clinical outcomes — not an opaque score.
IVF success rate variability
Wide variability across clinics, embryologists, and patient profiles makes a single benchmark hard to define and harder to defend.
Embryologist workflow fit
The system must augment, not disrupt, the existing embryologist's daily review and selection workflow — adoption is workflow-bound.
Regulatory and ethical considerations
Embryo grading touches medical ethics — explainability, human oversight, and patient consent are first-class design constraints, not afterthoughts.
02 / The Solution
A deep-learning embryo grading platform — flagshipped as Garbha.ai
AiSPRY built Garbha.ai — a deep-learning embryo quality prediction platform that ingests microscopy images of oocytes and embryos, classifies their morphological quality and developmental stage, and produces an objective embryo viability score with confidence intervals and feature-level explanations on every prediction.
The platform is grounded in what AiSPRY believes is the most extensive oocyte and embryo image dataset assembled in India, combined with pre-trained image-classification backbones — ResNet, EfficientNet, and Vision Transformer — adapted via transfer learning for fertility imagery. Multi-task learning produces embryo grade, developmental stage, and viability predictions side by side.
Every prediction surfaces alongside the embryologist's own review with visual heatmaps showing which morphological features drove the score — never replacing the clinician. An audit trail links every AI output to the human decision and the eventual clinical outcome, so accuracy is monitored longitudinally and the model keeps learning from real cycles. Recognized as a HYSEA 2025 National Award winner.
A walkthrough of the Garbha.ai embryo quality prediction platform — from microscopy image capture and preprocessing through CNN-based grading to the embryologist dashboard surfacing per-embryo viability scores, confidence intervals, and Grad-CAM-style heatmaps on every prediction.
Per-embryo viability scoring
Visual feature-attribution heatmaps
Embryologist-in-the-loop review
Outcome-linked accuracy tracking
04 / Architecture
Five-stage pipeline from microscopy image to clinical decision
From image capture in the IVF lab, through preprocessing and embryologist-labeled training data, into the deep-learning core, layered with explainability, and surfaced through clinical applications — embryologist-augmenting by design, not embryologist-replacing.
01 ▸ IMAGE CAPTURE
Standardized Microscopy
Time-lapse incubators and clinical microscopes, embryologist-labeled ground truth, outcome-linked annotations.
02 ▸ PREPROCESSING
Normalization & Localization
Normalization, denoising, embryo localization, automated quality control to filter unsuitable frames.
03 ▸ MODELS
CNN + ViT Ensemble
ResNet, EfficientNet, and Vision Transformer with transfer learning and multi-task heads for grade, stage, and viability.
04 ▸ EXPLAINABILITY
Embryologist-in-the-Loop
Confidence scoring, Grad-CAM-style heatmaps, audit trail linking every AI output to the human decision.
Each backbone captures different morphological cues in oocyte and embryo imagery. Ensembling with multi-task heads (grade, developmental stage, viability) produces predictions that are both accurate and explainable — when one backbone misses a feature, another picks it up.
Convolutional Net
ResNet
Deep residual networks pre-trained on ImageNet and adapted via transfer learning to embryo morphology — captures fine-grained texture and cell-boundary features that drive blastocyst grade.
Convolutional Net
EfficientNet
Compound-scaled CNN with strong accuracy-per-parameter tradeoff — efficient enough for clinic-side inference, sensitive enough to distinguish developmental stage and cytoplasmic quality.
Transformer
Vision Transformer
Attention-based image classification that excels at long-range structural patterns — picks up cohort-level morphology cues a strict convolutional receptive field can miss.
06 / Results
Embryo grading accuracy converted into measurable clinical outcomes
Garbha.ai was engineered to move three things at once — IVF success rates, embryologist productivity, and clinical economics — in the same direction. The headline targets validated the design and earned a HYSEA 2025 National Award.
Clinical outcomes
Targeted +15% uplift in IVF success rates
Objective, reproducible embryo grading across embryologists and shifts
Outcome-linked validation that holds up under clinical scrutiny
Faster, more confident embryo selection decisions
Consistent grading across cycles and centres
Embryologist-augmenting, never embryologist-replacing
ML accuracy & rigor
80%+ targeted prediction accuracy on embryo grading
Confidence-scored predictions with feature-level attribution
Visual Grad-CAM-style heatmaps on every prediction
Continuous accuracy uplift via embryologist-in-the-loop feedback
Validated against held-out cycles with outcome-linked ground truth
HYSEA 2025 National Award validation of impact and quality
Reduced cycle wastage from suboptimal embryo selection
Foundation for monetizable expansion across the IVF ecosystem
Audit-grade trail linking every prediction to clinical outcome
Privacy-safe pipelines that protect patient identity throughout
07 / Frequently Asked
Questions about the platform
What is Garbha.ai?
Garbha.ai is an AI-powered embryo quality prediction platform built by AiSPRY for IVF clinics. It uses deep learning and computer vision to objectively grade oocytes and embryos, replacing subjective manual scoring with reproducible, evidence-based predictions. Garbha.ai was recognized as a HYSEA 2025 National Summit & Awards winner.
How does Garbha.ai grade embryos?
Garbha.ai analyzes microscopy images of embryos using convolutional neural networks (CNNs) — ResNet, EfficientNet, and Vision Transformer backbones — trained on what AiSPRY believes is the most extensive oocyte and embryo image dataset assembled in India. The system produces a per-embryo viability score with confidence intervals and visual heatmaps showing which morphological features drove the prediction.
Does Garbha.ai replace embryologists?
No. Garbha.ai is embryologist-augmenting, not embryologist-replacing. The AI prediction surfaces alongside the embryologist's review, with visual heatmaps showing which features drove the prediction and an audit trail linking every AI output to the human decision. The embryologist remains the clinical decision-maker.
What ROI does Garbha.ai deliver for IVF clinics?
Garbha.ai targets a Year-1 ROI of 150%+ for IVF clinics, driven by a +15% uplift in IVF success rates, more confident embryo selection, and reduced cycle wastage from suboptimal grading. Higher per-cycle success rates translate directly into lower cost-per-live-birth for clinics and patients.
What other AI products does Garbha.ai offer beyond embryo grading?
Garbha.ai is expanding from embryo grading into a full fertility intelligence platform. Future modules include oocyte quality assessment, sperm selection, endometrial receptivity assessment (ERA), and pharmacogenomics (PGx) — all built around the same deep-learning and embryologist-in-the-loop philosophy.
- Bring objective, AI-powered embryo grading to your IVF clinic
Talk to the Garbha.ai team about deep-learning embryo selection for your fertility practice.
From oocyte and embryo grading to a full fertility intelligence platform — Garbha.ai grounds every prediction in the most extensive Indian oocyte and embryo image dataset, surfaces feature-attribution heatmaps on every score, and keeps the embryologist in the loop.